IκBζ-deficient mice showed inhibited development of IL-17-, IL-23- and imiquimod-induced psoriasis, and IκBζ-deficient keratinocytes attenuated IL-36–induced psoriasis-like dermatitis (125, 126). Here, NFKBIZ is linked to skin disorder.